Literature DB >> 12424591

Severe cleidocranial dysplasia can mimic hypophosphatasia.

Sheila Unger1, Etienne Mornet, Stefan Mundlos, Susan Blaser, David E C Cole.   

Abstract

UNLABELLED: Cleidocranial dysplasia (OMIM 119600) is a skeletal dysplasia caused by mutations in the bone/cartilage specific osteoblast transcription factor RUNX2 gene. It is characterised by macrocephaly with persistently open sutures, absent or hypoplastic clavicles, dental anomalies, and delayed ossification of the pubic bones. A few patients have been reported with recurrent fractures or osteoporosis but these are not considered features of the disease. We report a patient with classical findings of cleidocranial dysplasia: markedly hypoplastic clavicles, delayed ossification of the pubic rami, multiple pseudoepiphyses of the metacarpals, and dental anomalies including delayed eruption of permanent dentition and multiple supernumerary teeth. The patient also had radiographic and biochemical features of hypophosphatasia (OMIM 241500, 146300) and was initially diagnosed with this condition. Serum alkaline phosphatase activity has been consistently reduced and specific enzyme substrates, phosphoethanolamine and pyridoxal-5'-phosphate, have been elevated. However, no mutations were found on direct sequencing of the tissue-nonspecific alkaline phosphatase ( TNSALP) gene using a protocol that detects up to 94% of all mutations causing hypophosphatasia.
CONCLUSION: We propose that a subset of patients with cleidocranial dysplasia have features of secondary hypophosphatasia due to decreased expression of the tissue-nonspecific alkaline phosphatase gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424591     DOI: 10.1007/s00431-002-0978-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

Review 1.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

2.  Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2.

Authors:  Areeg H El-Gharbawy; Joseph N Peeden; Ralph S Lachman; John M Graham; Stephen R Moore; David L Rimoin
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

3.  Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia.

Authors:  Toshimi Michigami; Takayuki Uchihashi; Akira Suzuki; Kanako Tachikawa; Shigeo Nakajima; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2005-01-20       Impact factor: 3.183

Review 4.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

Review 5.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 6.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Cone-beam computed tomography: An inevitable investigation in cleidocranial dysplasia.

Authors:  Nandita S Gupta; Ajas A Gogri; Manasi M Kajale; Sonali G Kadam
Journal:  Contemp Clin Dent       Date:  2015 Apr-Jun

8.  Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for Memo1.

Authors:  Matthias B Moor; Suresh K Ramakrishnan; Finola Legrand; Silvia Dolder; Mark Siegrist; Fanny Durussel; Gabriel Centeno; Dmitri Firsov; Nancy E Hynes; Willy Hofstetter; Olivier Bonny
Journal:  JBMR Plus       Date:  2018-01-17

9.  Hypophosphatasia and cleidocranial dysplasia-a case report and review of the literature: the role of the neurosurgeon.

Authors:  Alexandros Blionas; Gerhard M Friehs; Vasileios A Zerris
Journal:  Childs Nerv Syst       Date:  2021-06-15       Impact factor: 1.475

10.  Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia.

Authors:  Maria Felicia Faienza; Annamaria Ventura; Laura Piacente; Maria Ciccarelli; Margherita Gigante; Loreto Gesualdo; Silvia Colucci; Luciano Cavallo; Maria Grano; Giacomina Brunetti
Journal:  Int J Med Sci       Date:  2014-02-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.